A detailed history of Human Investing LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Human Investing LLC holds 2,323 shares of LLY stock, worth $1.88 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
2,323
Previous 2,688 13.58%
Holding current value
$1.88 Million
Previous $2.38 Million 24.7%
% of portfolio
0.32%
Previous 0.43%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

SELL
$727.2 - $932.06 $265,428 - $340,201
-365 Reduced 13.58%
2,323 $1.79 Million
Q3 2024

Oct 28, 2024

SELL
$772.14 - $960.02 $57,138 - $71,041
-74 Reduced 2.68%
2,688 $2.38 Million
Q2 2024

Jul 17, 2024

BUY
$724.87 - $909.04 $1,449 - $1,818
2 Added 0.07%
2,762 $2.5 Million
Q1 2024

Apr 25, 2024

SELL
$592.2 - $792.28 $13,620 - $18,222
-23 Reduced 0.83%
2,760 $2.15 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $191,694 - $225,982
-365 Reduced 11.59%
2,783 $1.62 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $27,386 - $37,755
-63 Reduced 1.96%
3,148 $1.69 Million
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $62,782 - $83,947
-179 Reduced 5.28%
3,211 $1.51 Million
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $34,169 - $40,130
-110 Reduced 3.14%
3,390 $1.16 Million
Q4 2022

Jan 27, 2023

SELL
$321.55 - $374.67 $378,785 - $441,361
-1,178 Reduced 25.18%
3,500 $0
Q3 2022

Oct 31, 2022

SELL
$296.48 - $337.87 $35,281 - $40,206
-119 Reduced 2.48%
4,678 $1.51 Million
Q2 2022

Jul 27, 2022

SELL
$278.73 - $327.27 $87,521 - $102,762
-314 Reduced 6.14%
4,797 $1.56 Million
Q1 2022

May 05, 2022

BUY
$234.69 - $291.66 $1.2 Million - $1.49 Million
5,111 New
5,111 $1.46 Million
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $1.25 Million - $1.55 Million
-5,554 Closed
0 $0
Q3 2021

Nov 04, 2021

SELL
$221.6 - $272.71 $285,642 - $351,523
-1,289 Reduced 18.84%
5,554 $1.28 Million
Q2 2021

Aug 02, 2021

SELL
$180.55 - $233.54 $54,345 - $70,295
-301 Reduced 4.21%
6,843 $1.57 Million
Q1 2021

May 05, 2021

SELL
$164.32 - $212.72 $226,432 - $293,128
-1,378 Reduced 16.17%
7,144 $1.34 Million
Q4 2020

Feb 04, 2021

SELL
$130.46 - $172.63 $17,742 - $23,477
-136 Reduced 1.57%
8,522 $1.44 Million
Q3 2020

Oct 27, 2020

SELL
$146.22 - $169.13 $800,993 - $926,494
-5,478 Reduced 38.75%
8,658 $1.28 Million
Q2 2020

Jul 22, 2020

SELL
$136.42 - $164.18 $229,322 - $275,986
-1,681 Reduced 10.63%
14,136 $2.32 Million
Q1 2020

Apr 22, 2020

BUY
$119.05 - $147.35 $419,889 - $519,703
3,527 Added 28.7%
15,817 $2.19 Million
Q4 2019

Feb 07, 2020

BUY
$106.92 - $132.43 $14,754 - $18,275
138 Added 1.14%
12,290 $1.62 Million
Q3 2019

Nov 07, 2019

SELL
$106.79 - $116.16 $23,066 - $25,090
-216 Reduced 1.75%
12,152 $1.36 Million
Q2 2019

Aug 16, 2019

SELL
$110.79 - $129.32 $57,056 - $66,599
-515 Reduced 4.0%
12,368 $1.37 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $1.44 Million - $1.69 Million
-12,901 Reduced 50.03%
12,883 $1.67 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $2.73 Million - $3.06 Million
25,784 New
25,784 $2.98 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Human Investing LLC Portfolio

Follow Human Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.